Company Overview of Pericor Science Incorporated
Pericor Science Incorporated, a development stage biopharmaceutical company, develops therapeutics by using the TransLink System to enhance existing drugs or therapeutic molecules. Its lead compound, PTI 101, is a TransLink direct thrombin inhibitor for thrombosis and stenosis. The company was founded in 1999 and is based in Boston, Massachusetts.
50 Rowes Wharf
Boston, MA 02110
Founded in 1999
Key Executives for Pericor Science Incorporated
Similar Private Companies By Industry
|Immune Response BioPharma, Inc.||United States|
|B.F. Ascher & Company, Inc.||United States|
|Extinction Pharmaceuticals, Inc.||United States|
|Copperhead Chemical Company Inc.||United States|
|Breakthrough Products, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Pericor Science Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.